Issue navigation
Volume 134, Issue Supplement_1, August 1976
Articles
Participants of the Symposium on Tobramycin at the Ninth International Congress of Chemotherapy
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Page S1, https://doi.org/10.1093/infdis/134.Supplement_1.S1
Foreword
Maxwell Finland
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Page S2, https://doi.org/10.1093/infdis/134.Supplement_1.S2
Tobramycin: An Overview
Harold C. Neu
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S3–S19, https://doi.org/10.1093/infdis/134.Supplement_1.S3
Microbiology and Biochemistry
Laboratory Findings on Tobramycin and Their Relation to Clinical Response
T. A. McAllister and Susan C. Tait
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S20–S27, https://doi.org/10.1093/infdis/134.Supplement_1.S20
Susceptibility of Nontermentative Gram-Negative Bacilli to Tobramycin
Marwan Uwaydah and Abdul-Razzak Taqi-Eddin
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S28–S32, https://doi.org/10.1093/infdis/134.Supplement_1.S28
Tobramycin Adenylyltransferase: A New AminoglycosideInactivating Enzyme from Staphylococcus epidermidis
Partha Santanam and Fritz H. Kayser
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S33–S39, https://doi.org/10.1093/infdis/134.Supplement_1.S33
Emergence of Gentamicin-Resistant Bacteria: Experience with Tobramycin Therapy of Infections Due to Gentamicin-Resistant Organisms
Robert C. Moellering and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S40–S49, https://doi.org/10.1093/infdis/134.Supplement_1.S40
Comparative in Vitro Activity of Tobramycin, Gentamicin, Kanamycin, Colistin, Carbenicillin, and Ticarcillin on Clinical Isolates of Pseudomonas aeruginosa: Epidemiological and Therapeutic Implications
H. L. C. Dulong de Rosnay and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S50–S56, https://doi.org/10.1093/infdis/134.Supplement_1.S50
Susceptibility of “Enterobacteria” to Aminoglycoside Antibiotics: Comparisons with Tetracyclines, Polymyxins, Chloramphenicol, and Spectinomycin
Maxwell Finland and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S57–S74, https://doi.org/10.1093/infdis/134.Supplement_1.S57
Susceptibility of “Enterobacteria” to Penicillins, Cephalosporins, Lincomycins, Erythromycin, and Rifampin
Maxwell Finland and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S75–S96, https://doi.org/10.1093/infdis/134.Supplement_1.S75
Pharmacology and Toxicity
Aspects of the Pharmacology and Toxicology of Tobramycin in Animals and Humans
K. S. Israel and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S97–S103, https://doi.org/10.1093/infdis/134.Supplement_1.S97
Rapid Microbiologic Assay of Tobramycin
D. C. Shanson and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S104–S109, https://doi.org/10.1093/infdis/134.Supplement_1.S104
Rapid Intravenous Injection of Tobramycin: Suggested Dosage Schedule and Concentrations in Serum
A. P. Gillett and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S110–S113, https://doi.org/10.1093/infdis/134.Supplement_1.S110
Intravenous Injection of Gentamicin and Tobramycin without Impairment of Hearing
Sylvia M. Dobbs and G. E. Mawer
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S114–S117, https://doi.org/10.1093/infdis/134.Supplement_1.S114
Pharmacokinetics of Intravenously Administered Tobramycin in Normal Volunteers and in Renal-Impaired and Hemodialyzed Patients
Jean-Claude Péchère and Robert Dugal
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S118–S124, https://doi.org/10.1093/infdis/134.Supplement_1.S118
Administration of Tobramycin and Gentamicin by the Intravenous Route Every 6 Hr in Patients with Normal Renal Function
Usha Setia and Peter A. Gross
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S125–S129, https://doi.org/10.1093/infdis/134.Supplement_1.S125
Pharmacokinetics of Tobramycin in Rats with Reduced Renal Parenchyma and in Experimental Shock
Josef Morávek and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S130–S132, https://doi.org/10.1093/infdis/134.Supplement_1.S130
Comparison of Urinary Excretion of Tobramycin and Gentamicin in Adults
M. J. Wood and W. Farrell
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S133–S138, https://doi.org/10.1093/infdis/134.Supplement_1.S133
Clinical Studies: Urinary Tract Infections
Clinical Evaluation of Tobramycin in Urinary Tract Infections
P. Altucci and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S139–S141, https://doi.org/10.1093/infdis/134.Supplement_1.S139
Single Daily Doses of Tobramycin in Therapy of Urinary Tract Infections
Ralph R. Landes
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S142–S145, https://doi.org/10.1093/infdis/134.Supplement_1.S142
A Randomized, Comparative Study of Tobramycin and Gentamicin in Treatment of Acute Urinary Tract Infections
Brian D. Walker and Layne O. Gentry
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S146–S149, https://doi.org/10.1093/infdis/134.Supplement_1.S146
Comparison of Tobramycin and Gentamicin in the Treatment of Complicated Urinary Tract Infections
Paul O. Madsen and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S150–S152, https://doi.org/10.1093/infdis/134.Supplement_1.S150
Bacteriological, Clinical, and Pharmacological Investigations with Tobramycin in Patients with Serious Urinary Tract Infection
Éva Iván and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S153–S155, https://doi.org/10.1093/infdis/134.Supplement_1.S153
Evaluation of Tobramycin in Severe Urinary Tract Infection
Alan H. Bennett
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S156–S157, https://doi.org/10.1093/infdis/134.Supplement_1.S156
Clinical Studies: Other Infections
Laboratory and Clinical Evaluation of Tobramycin, aNew Aminoglycoside Antibiotic
E. Escárzaga and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S158–S164, https://doi.org/10.1093/infdis/134.Supplement_1.S158
Tobramycin in Pediatric Use
P. A. M. Raine and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S165–S169, https://doi.org/10.1093/infdis/134.Supplement_1.S165
Tobramycin and Cephalothin Sodium in Treatment of Infected Patients with Acute Leukemia
P. C. Vincent and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S170–S174, https://doi.org/10.1093/infdis/134.Supplement_1.S170
Tobramycin and Cephalothin for Treatment of Suspected Sepsis in Neutropenic Children with Cancer
Jesse D. Cohen and Thomas D. Miale
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S175–S177, https://doi.org/10.1093/infdis/134.Supplement_1.S175
Clinical Use of Tobramycin in Patients with Surgical Infections Due to Gram-Negative Bacilli
S. Ishiyama and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S178–S181, https://doi.org/10.1093/infdis/134.Supplement_1.S178
Clinical Evaluation of Tobramycin in Respiratory and Systemic Infections in Immunodepressed and Normal Patients
P. Altucci and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S182–S186, https://doi.org/10.1093/infdis/134.Supplement_1.S182
Tobramycin in Treatment of Infections Due to Pseudomonas aeruginosa in Patients with Cystic Fibrosis
Douglas N. Crozier and Shahida R. Khan
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S187–S190, https://doi.org/10.1093/infdis/134.Supplement_1.S187
Tobramycin Therapy of Infections Due to Pseudomonas aeruginosa in Patients with Cystic Fibrosis: Effect of Dosage and Concentration of Antibiotic in Sputum
W. Morrice McCrae and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S191–S193, https://doi.org/10.1093/infdis/134.Supplement_1.S191
Tobramycin and Ticarcillin Therapy for Exacerbations of Pulmonary Disease in Patients with Cystic Fibrosis
Michael F. Parry and Harold C. Neu
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S194–S199, https://doi.org/10.1093/infdis/134.Supplement_1.S194
Adverse Reactions
Pharmacokinetics and Ototoxicity of Gentamicin, Tobramycin, and Amikacin
P. Federspil and others
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S200–S205, https://doi.org/10.1093/infdis/134.Supplement_1.S200
Ototoxicity of Tobramycin: A Clinical Overview
Harold C. Neu and Cecil L. Bendush
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S206–S218, https://doi.org/10.1093/infdis/134.Supplement_1.S206
Clinical Summary
Tobramycin Sulfate: A Summary of Worldwide Experience from Clinical Trials
Cecil L. Bendush and Ruth Weber
The Journal of Infectious Diseases, Volume 134, Issue Supplement_1, August 1976, Pages S219–S234, https://doi.org/10.1093/infdis/134.Supplement_1.S219
Advertisement
Advertisement